Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection-Reference-Cited by-同舟云学术

Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection

Published:2021-05-26 Issue:6 Volume:15 Page:737-744
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Zhang Yang¹,Hill Adam T¹²

Affiliation:

1. Centre for Inflammation Research, Centre for Inflammation Research at the University of Edinburgh, Queen’s Medical Research Institute, Edinburgh BioQuarter, Edinburgh, Scotland

2. Department of Respiratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, Scotland

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2021.1875821

Reference55 articles.

1. Species Identification of Mycobacterium avium Complex Isolates by a Variety of Molecular Techniques

2. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

3. Mechanism of mycobacterium avium complex pathogenesis

4. Nontuberculous Mycobacterial Disease Mortality in the United States, 1999–2010: A Population-Based Comparative Study

5. The Rise of Non-Tuberculosis Mycobacterial Lung Disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery;Respiratory Research;2022-12-24

2. Advances in Nanostructures for Antimicrobial Therapy;Materials;2022-03-24

3. Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections;International Journal of Pharmaceutics;2022-03

4. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives;Molecules;2022-02-17